Pancreatitis pain ranges from a manageable ache to some of the worst abdominal pain a person can experience, and the treatments that work depend heavily on whether the inflammation is a single acute episode or a chronic, recurring condition. For an acute flare, the standard approach combines intravenous fluids, nothing-by-mouth rest, and escalating pain medications. For chronic pancreatitis, relief often requires layering multiple strategies: nerve-targeting drugs like pregabalin, enzyme supplements, endoscopic procedures to clear blockages, and in severe cases, surgery. The frustrating reality is that no single treatment eliminates the pain for everyone, but the evidence points to specific interventions that genuinely help at each stage.
Why Pancreatitis Pain Is So Difficult to Control
Understanding why the pain is so stubborn helps explain why treatment often needs to be aggressive and multimodal. In acute pancreatitis, injured pancreatic tissue and the nerves running through it enter a feedback loop: damaged cells release inflammatory molecules, those molecules activate pain-sensing nerve fibers, and the activated nerves release their own inflammatory signals back into the tissue. This “neurogenic inflammation” amplifies both the tissue damage and the pain perception simultaneously.1Europe PMC. Molecular mechanisms of pain in acute pancreatitis: recent basic research advances and therapeutic implications
In chronic pancreatitis, the problem goes deeper. Repeated injury rewires the nervous system itself. Pancreatic nerve fibers become thicker and more numerous, immune cells infiltrate the nerve bundles, and the nerves become hypersensitive to stimuli that would not normally cause pain. Over time, the spinal cord neurons that relay pain signals from the pancreas also become hyperexcitable, a process called central sensitization. Eventually, even the brain’s sensory cortex reorganizes in response, which means the pain system has been altered at every level from the organ to the brain.2PubMed Central. Pain mechanisms in chronic pancreatitis: of a master and his fire This is why chronic pancreatitis pain can persist even after the original inflammation has quieted or the pancreatic duct has been cleared. The nervous system has learned to generate pain on its own.3PubMed Central. Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment
Managing Pain During an Acute Attack
When someone arrives at a hospital with acute pancreatitis, the immediate priorities are fluids, pain control, and monitoring for complications. Intravenous hydration has long been considered essential because the inflamed pancreas and surrounding tissue leak fluid. However, recent evidence has shifted thinking about how aggressively to hydrate. A major randomized trial published in the New England Journal of Medicine found that aggressive fluid resuscitation did not reduce the rate of moderate-to-severe pancreatitis compared with moderate resuscitation, and roughly one in five patients given aggressive fluids developed fluid overload.4N Engl J Med. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis Most centers have since moved toward a more measured approach to IV fluids.
For the pain itself, the old fear that opioids would worsen pancreatitis by causing spasm of the sphincter of Oddi has not held up. Meta-analyses comparing opioids to non-opioid painkillers in acute pancreatitis have found no significant increase in complications, nausea, or deaths with opioid use.5Gastro Hep Advances. A Systematic Review and Meta-analysis of Opioids vs Nonopioids in Acute Pancreatitis When researchers looked specifically at NSAIDs versus opioids, the two classes performed similarly for pain intensity, with no clear winner on the need for rescue medication.6Frontiers in Medicine. Pain Management in Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
That said, the picture is not perfectly even. A randomized trial comparing the opioid buprenorphine with the NSAID diclofenac found that buprenorphine provided longer pain-free intervals and greater reductions in pain scores over three days, even in patients with more severe disease.7Clinical Gastroenterology and Hepatology. Buprenorphine Versus Diclofenac for Pain Relief in Acute Pancreatitis: A Double-Blinded Randomized Controlled Trial In practice, most hospitals start with acetaminophen or an NSAID and escalate to opioids if those are not enough, which is a reasonable approach given the current data. The key point is that opioids should not be withheld from someone in severe pain out of a misplaced concern that they will make the pancreatitis worse.
Pregabalin and Other Nerve-Targeting Medications
Because chronic pancreatitis pain involves sensitized nerves and altered spinal cord signaling, medications designed for neuropathic pain can make a real difference. Pregabalin, originally developed for epilepsy and later approved for nerve pain conditions, is the best studied of these drugs in pancreatitis. In a randomized controlled trial, patients taking pregabalin had meaningful pain score improvements compared to placebo after three weeks, with about 44% reporting much or very much improved health status versus 21% on placebo.8Gastroenterology. Pregabalin Reduces Pain in Patients With Chronic Pancreatitis in a Randomized, Controlled Trial A Cochrane review of the same trial confirmed that pregabalin also reduced the amount of opioid medication patients needed.9PubMed Central. Pregabalin for decreasing pancreatic pain in chronic pancreatitis
The catch is that pregabalin causes side effects like dizziness, brain fog, and drowsiness in some people, so it often needs to be started at low doses and increased gradually. It also does not work for everyone. Interestingly, researchers have found that a specialized nerve-sensitivity test called quantitative sensory testing can predict with about 84% accuracy which patients will respond to pregabalin.10PLOS ONE. Quantitative Sensory Testing Predicts Pregabalin Efficacy in Painful Chronic Pancreatitis That kind of personalized targeting is still confined to research settings, but it points toward a future where treatment can be matched to a patient’s specific pain biology rather than tried one drug at a time.
Pancreatic Enzyme Supplements
This one surprises a lot of people: taking digestive enzyme capsules with meals can help with chronic pancreatitis pain, not just with digestion. The theory is straightforward. When the pancreas is not releasing enough enzymes into the small intestine, the gut keeps sending hormonal signals demanding more secretion. That drives up pressure inside the pancreatic ducts, worsens tissue ischemia, and generates pain. Supplementing with oral enzymes essentially satisfies the gut’s demand and turns down that feedback loop.11PubMed Central. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes
The evidence for enzyme therapy specifically for pain is mixed: some trials show meaningful reductions, while others do not. But for patients who also have exocrine insufficiency, which means difficulty digesting food, enzymes are prescribed regardless, and any pain benefit is a welcome bonus. They are safe, widely available by prescription, and worth trying as one part of a broader pain strategy.
Quitting Alcohol and Tobacco
If there is one piece of advice that applies across nearly all pancreatitis patients, it is this: stop drinking alcohol and stop smoking. A study comparing patients who continued drinking with those who quit found that former drinkers were dramatically more likely to be relapse-free (37% versus 5%), had lower rates of exocrine insufficiency, and experienced less abdominal pain.12PubMed. Impact of alcohol and smoking cessation on the course of chronic pancreatitis Smoking cessation also helped, though its effect on relapse rates was smaller. The practical message is that these two lifestyle changes are not merely general health advice; they directly slow disease progression and reduce pain episodes in ways that medications struggle to match.
Dietary Adjustments That Actually Help
Fat is the main dietary trigger for pancreatitis pain. Eating fat stimulates the release of cholecystokinin in the small intestine, which drives pancreatic secretion and increases duct pressure. For patients with chronic pancreatitis, restricting dietary fat and supplementing with a very low-fat elemental formula reduced pain in the large majority of cases studied.13PubMed Central. Beneficial Effect of Low-Fat Elemental Diet Therapy on Pain in Chronic Pancreatitis In practice, this means eating smaller, more frequent meals with modest fat content rather than large, rich meals. Some patients find that keeping a food diary helps them identify personal triggers beyond just fat, since the threshold varies from person to person.
Antioxidant supplementation has also attracted attention, based on the idea that oxidative stress contributes to ongoing pancreatic damage and pain. At least one large randomized trial found that a combination of antioxidants led to significant pain reduction in patients with alcoholic or idiopathic chronic pancreatitis.14PubMed. Chronic pancreatitis: role of oxidative stress and antioxidants The typical regimen includes selenium, vitamin C, vitamin E, beta-carotene, and methionine. Results have been inconsistent across studies, so antioxidants are best viewed as a potential addition to other treatments rather than a standalone solution.
Celiac Plexus Block
The celiac plexus is a bundle of nerves behind the pancreas that relays pain signals to the brain. Injecting it with a local anesthetic and a steroid, guided by endoscopic ultrasound, can temporarily block those signals. A systematic review and meta-analysis found that about half of patients respond to this procedure, with pain relief lasting a median of roughly 80 days.15PubMed. Endoscopic ultrasound-guided celiac plexus block for painful chronic pancreatitis: A systematic review and meta-analysis The effect fades, though: by 12 weeks, only about one in five patients still had meaningful benefit, and by six months almost none did.
An earlier randomized trial found similar numbers, with about 55% of patients getting relief that lasted a median of roughly four weeks.16Gastrointestinal Endoscopy. A prospective randomized trial of 1-injection versus 2-injections endoscopic ultrasound-guided celiac plexus block in patients with chronic pancreatitis pain Neither the number of injections nor patient demographics predicted who would respond well. The procedure is generally safe, but its temporary nature means it is best used as a bridge while other treatments are optimized, not as a long-term fix on its own.
Endoscopic Procedures for Blocked Ducts
When chronic pancreatitis causes stones or strictures that obstruct the main pancreatic duct, relieving that obstruction can reduce pain substantially. The most common approach combines extracorporeal shock wave lithotripsy (ESWL), which uses sound waves to break up pancreatic stones, with endoscopic retrograde pancreatography (ERP) to clear the fragments and place stents. A meta-analysis found that this combination achieves complete duct clearance in most patients and leads to pain-free follow-up in over half.17PubMed Central. Success of extracorporeal shock wave lithotripsy and ERCP in symptomatic pancreatic duct stones: a systematic review and meta-analysis One series reported complete pain resolution in about half of patients after ESWL and stenting, with pain improvement in close to 90%.18PubMed. Extracorporeal shock wave lithotripsy with a transportable mini-lithotripter and subsequent endoscopic treatment improves clinical outcome in obstructive calcific chronic pancreatitis
A sham-controlled trial provided more measured results. At 12 weeks, patients who received ESWL plus endoscopy had better pain scores and gained about 16 extra pain-free days compared to the sham group. But by 24 weeks, the difference between the groups was no longer statistically significant.19PubMed. Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis: A Sham-Controlled, Randomized Trial That finding is a useful reality check: duct clearance helps, but it may need to be repeated, and not all chronic pancreatitis pain comes from duct obstruction. When the nervous system has already become independently sensitized, as described earlier, unblocking the duct alone will not be enough.
When Surgery Outperforms Endoscopy
For patients whose pain is driven by duct obstruction or an enlarged pancreatic head, surgery has consistently outperformed repeated endoscopic treatments. In a landmark randomized trial, surgical drainage of the pancreatic duct produced complete or partial pain relief in 75% of patients over two years, compared with 32% for endoscopic drainage. Patients in the endoscopy group also needed far more procedures, a median of eight versus three.20PubMed. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis
Another trial comparing the two approaches found that at five years, complete absence of pain was more than twice as common after surgery versus endoscopic therapy.21PubMed. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis Long-term follow-up from the ESCAPE trial reinforced this: patients randomized to early surgery had lower pain scores and were more than twice as likely to achieve complete pain relief compared with those managed endoscopically first.22JAMA Surgery. Long-Term Outcomes of Early Surgery vs Endoscopy First in Chronic Pancreatitis: Follow-Up Analysis of the ESCAPE Randomized Clinical Trial
The practical takeaway is that many patients spend years cycling through endoscopic procedures before being referred for surgery, and the accumulating evidence suggests that earlier surgical intervention often leads to better pain control. Surgery is not a guarantee, and it carries its own risks, but the data consistently favors it over endoscopy for patients with obstructive disease who are surgical candidates.
Total Pancreatectomy With Islet Autotransplant
When nothing else works, removing the entire pancreas is sometimes the only remaining option. The obvious problem is that without a pancreas, you develop insulin-dependent diabetes. Total pancreatectomy with islet autotransplantation (TPIAT) addresses this by harvesting your own insulin-producing islet cells from the removed pancreas and infusing them into your liver, where they can continue to produce some insulin.
A prospective multicenter study tracked patients after TPIAT and found that the proportion reporting constant pain dropped from 63% before surgery to 15% at one year. Daily opioid use fell from 46% to 20%, and any opioid use dropped from 61% to 24%.23Gastroenterology. Evaluation of Total Pancreatectomy With Islet Autotransplantation for Intractable Chronic and Recurrent Acute Pancreatitis: A Prospective Multicenter Study Roughly two-thirds of well-selected patients achieve narcotic independence, though about 10 to 20% will continue to have persistent or minimally improved symptoms.24PubMed Central. Islet Autotransplantation and Total Pancreatectomy
TPIAT is reserved for patients who have exhausted medical and endoscopic options and continue to suffer debilitating pain.25PubMed Central. A multicenter study of total pancreatectomy with islet autotransplantation (TPIAT): POST (Prospective Observational Study of TPIAT) It is a major, irreversible surgery, and even with islet transplant, many patients still require some insulin supplementation. But for the right person, it can be transformative.
Cognitive Behavioral Therapy for Pancreatitis Pain
Chronic pain rewires the brain, and pancreatitis is no exception. Anxiety, depression, and catastrophizing thinking patterns amplify pain perception and make it harder to function. Cognitive behavioral therapy (CBT) directly targets those psychological amplifiers. A pilot randomized trial of an internet-delivered CBT program for chronic pancreatitis patients found moderate to large reductions in both pain intensity and pain interference over three months. Half of the CBT group met the threshold for clinically meaningful improvement (a 30% or greater reduction), compared with just 13% of those in the control group.26PubMed Central. Cognitive-Behavioral Therapy for Painful Chronic Pancreatitis: A Pilot Feasibility Randomized Controlled Trial
Those results were promising enough that a larger hybrid trial is now underway to test digital CBT in a bigger sample and gather data on how to implement it widely.27Trials. Digital cognitive-behavioral therapy for pain management in individuals with recurrent acute and chronic pancreatitis (IMPACT-2): study protocol for a hybrid effectiveness-implementation trial CBT is not going to replace medications or procedures, but it addresses a dimension of chronic pain that pills cannot reach. For patients stuck in a cycle of pain, opioid dependence, and depression, adding CBT is one of the more evidence-supported things they can do.
Medical Cannabis and Other Emerging Options
Interest in medical cannabis for chronic pancreatitis pain is growing, though the evidence is still thin. Observational data suggest it may help some patients reduce their opioid use.28Clinical Gastroenterology and Hepatology. Effects of Medical Cannabis on Use of Opioids and Hospital Visits by Patients With Painful Chronic Pancreatitis Case reports describe patients whose pain improved substantially when conventional treatments had failed.29PubMed Central. Medical cannabis for the management of pain in chronic pancreatitis with recurrent exacerbations: a case report But no randomized controlled trials have been completed, so it is impossible to know how much of the reported benefit is a placebo effect or reflects patient self-selection. For patients in states or countries where it is legally accessible and who have not responded adequately to standard therapy, it is a reasonable conversation to have with a doctor, but it is not yet an evidence-based recommendation.
Electroacupuncture has been explored in acute pancreatitis as well. One small study found that patients who received it had higher levels of an anti-inflammatory marker and lower levels of a key inflammation marker compared with controls, suggesting it may reduce the inflammatory component of pain.30PubMed. Effect of electroacupuncture on the inflammatory response in patients with acute pancreatitis: an exploratory study It did not shorten hospital stays, and the study was too small to draw firm conclusions about pain outcomes. Like cannabis, it is an area where the mechanistic rationale is plausible but the clinical evidence is nowhere near strong enough to make it a standard recommendation.
The Pediatric Gap
Children get chronic pancreatitis too, and their pain management is alarmingly understudied. A scoping systematic review found zero published studies of analgesic medications, antioxidants, dietary modifications, integrative medicine, or nerve blocks specifically in children with chronic pancreatitis.31PubMed Central. Outpatient Pain Management In Children With Chronic Pancreatitis: A Scoping Systematic Review That is not a typo. Pediatric gastroenterologists are essentially extrapolating from adult data, which is far from ideal given differences in drug metabolism, pain psychology, and disease course in kids. If you have a child with chronic pancreatitis, finding a center with specific pediatric pancreatitis expertise matters more than for almost any other condition, because the standard playbook simply does not exist in the same way.
Matching Treatment to the Source of Pain
One reason pancreatitis pain management frustrates both patients and doctors is that “pancreatitis pain” is not one thing. Duct obstruction pain responds to procedures that clear the blockage. Inflammatory pain responds to anti-inflammatory medications and enzyme therapy. Neuropathic pain, where the nerves themselves have become the problem, responds to drugs like pregabalin and to nerve blocks. And centrally sensitized pain, where the spinal cord and brain have reorganized, may respond best to psychological approaches and centrally acting medications.
Quantitative sensory testing is beginning to offer a way to sort patients into these categories. A study in Indian patients with chronic pancreatitis confirmed that the test reliably detects widespread hyperalgesia and central sensitization across diverse populations.32PubMed. Pancreatic quantitative sensory testing (P-QST) for pain assessment in Indian patients with chronic pancreatitis As noted earlier, this same type of testing has been shown to predict who will respond to pregabalin with high accuracy.10PLOS ONE. Quantitative Sensory Testing Predicts Pregabalin Efficacy in Painful Chronic Pancreatitis The hope is that this approach will eventually allow clinicians to profile each patient’s pain mechanism and choose treatments accordingly, rather than working through a generic ladder of options. That kind of precision is still emerging, but it represents the most promising direction in pancreatitis pain research right now.